Showing Form 4 filings for AIM
Pre-configured institutional-grade criteria for instant high-conviction screening
Multiple insiders buying stock within the last 30 days
Direct open-market purchases by Chief Executive Officers
Financial chiefs and top corporate officers accumulating shares
Institutional-scale insider purchases of $1,000,000 or greater
Insiders increasing their overall equity ownership by over 20%
High-value executive divestments by CEOs and CFOs over $1M
Aim Immunotech Inc.
Price
$0.13
Shares
20,000
Ownership
386,095
Value/Share
Equels Thomas K
CEO, Pres
Unknown
Industry
$0.15
35,000
328,095
AIM
$0.16
31,675
189,747
31,250
158,072
$0.21
24,000
126,822
11,000
102,822
$0.22
22,000
91,822
5,900
69,822
$7.70
107
38,885
$8.70
103
38,675
$0.03
1,968,504
3,720,504
Kellner Ted D
Dir
3,867,533
196,851
522,103
Mitchell William M
$0.06
41,000
1,899,029
$0.09
500
401,762
Rodino Peter W III
COO, Secretary, Gen. Counsel
50,000
1,858,029
$0.12
44,000
1,808,029
83,334
1,764,029
1,657,968
$0.19
4,580
118,929
22,727
1,680,695
11,112
355,509
Appelrouth Stewart
$0.20
85,000
1,637,968
81,953
321,752
$0.18
60,110
1,552,968